Biosafety and Biosecurity in European Containment Level 3 Laboratories: Focus on French Recent Progress and Essential Requirements

Tierno, 2012, Biosecurity, biosafety and reference laboratories: the impact of national and European regulations concerning biological containment levels 3 and 4, Euro Ref, 1

2004, Laboratory Biosafety Manual

Kozajda, 2013, Factors influencing biosafety level and LAI among the staff of medical laboratories, Med Pr, 64, 473

Wei, 2011, [Preliminary studies on pathogenic microorganisms laboratory-acquired infections cases in recent years and its control strategies], Chin J Exp Clin Virol, 25, 390

Wurtz, 2016, Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories, Eur J Clin Microbiol Infect Dis, 35, 1247, 10.1007/s10096-016-2657-1

Pike, 1976, Laboratory-associated infections: summary and analysis of 3921 cases, Health Lab Sci, 13, 105

Byers, 2006, Epidemiology of laboratory-associated infections, Biological Safety Principles and Practices, 53

2017, Possession, use, and transfer of select agents and toxins; biennial review of the list of select agents and toxins and enhanced biosafety requirements. Final rule, Fed Regist, 82, 6278

Henkel, 2012, Monitoring select agent theft, loss and release reports in the United States – 2004-2010, Appl Biosaf, 17, 171, 10.1177/153567601201700402

Traxler, 2013, A literature review of laboratory-acquired brucellosis, J Clin Microbiol, 51, 3055, 10.1128/JCM.00135-13

Coelho, 2015, Biological risks and laboratory-acquired infections: a reality that cannot be ignored in health biotechnology, Front Bioeng Biotechnol, 3, 56, 10.3389/fbioe.2015.00056

Mourya, 2014, Establishment of biosafety level-3 (BSL-3) laboratory: important criteria to consider while designing, constructing, commissioning & operating the facility in Indian setting, Indian J Med Res, 140, 171

Tian, 2014, Comparison and analysis of biological agent category lists based on biosafety and biodefense, PLoS One, 9, e101163, 10.1371/journal.pone.0101163

2014, Global Action Plan to Minimize Poliovirus Facility-Associated Risk after Type-Specific Eradication of Wild Polioviruses and Sequential Cessation of OPV Use

Arita, 2017, Poliovirus studies during the endgame of the polio eradication program, Jpn J Infect Dis, 70, 1, 10.7883/yoken.JJID.2016.356

Devaux, 2015, The hidden face of academic researches on classified highly pathogenic microorganisms, Infect Genet Evol, 29, 26, 10.1016/j.meegid.2014.10.028

Hottes, 2012, Biosecurity Challenges of the Global Expansion of High-Containment Biological Laboratories

2009, Biosafety in Microbiological and Biomedical Laboratories (BMBL)

2014, BSL-3 and ABSL-3 HVAC System Requirements – Part I, 01

Crane, 1999, Design of BSL3 Laboratories (Chapter 7), Appl Biosaf, 4, 17, 10.1177/109135059900400106

Richards, 2014, BSL-3 laboratory practices in the United States: comparison of select agent and non–select agent facilities, Biosecur Bioterror, 12, 1, 10.1089/bsp.2013.0060

Thomas, 2013, Particle size and pathogenicity in the respiratory tract, Virulence, 4, 847, 10.4161/viru.27172

Rego, 1999, In-use barrier integrity of gloves: latex and nitrile superior to vinyl, Am J Infect Control, 27, 405, 10.1016/S0196-6553(99)70006-4

Kramer, 2014, Survival of microorganisms on inanimate surfaces, Use of Biocidal Surfaces for Reduction of Healthcare Acquired Infections, 7, 10.1007/978-3-319-08057-4_2

Gebel, 2013, The role of surface disinfection in infection prevention, GMS Hyg Infect Control, 8, Doc10, 10.3205/dgkh000210

Butaye, 2013, Disinfection and decontamination, Working in Biosafety Level 3 and 4 Laboratories, 59, 10.1002/9783527675357.ch7

Maris, 2014, Methodological guide to the implementation of a process for airborne surface disinfection applied to containment areas, Euro Ref, 12, 10

2015, Guidance on Regulations for the Transport of Infectious Substances 2015–2016

Bielecka, 2014, State-of-the-art in biosafety and biosecurity in European countries, Arch Immunol Ther Exp (Warsz), 62, 169, 10.1007/s00005-014-0290-1

2008, CWA 15793. Laboratory Biorisk Management Standard

Byers, 2013, Book review: management principles for building and operating biocontainment facilities: ten years of planning and management lessons learned, Appl Biosaf, 18, 153, 10.1177/153567601301800312

Weiss, 2010, Commissioning a Biocontainment Facility for Accreditation/Certification – Part 3

Allix, 2013, Implementation of the next French regulations on microorganisms and toxins: ANSE’s experience, Euro Ref, 5